Asgard Therapeutics AB
559184-0136ActivePioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Översikt
- 10–19
- Anställda
- ≤1t SEK
- Omsättning
- 2018
- Grundat
Nyckelbeslutsfattare
Cristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Alexey Zeifman
Board Member
Philipp Müller
Board Member
+26 fler kontakter i Funnelfeedr
Beskrivning
Asgard Therapeutics is a Swedish private biotech company focused on revolutionizing cancer immunotherapy. Their core mission involves pioneering direct cell reprogramming technologies. Specifically, they aim to develop scalable methods for the in vivo conversion of cancer cells into functional antig...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559184013601
Beslutsfattare
30 kontakter i FunnelfeedrCristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Alexey Zeifman
Board Member
Philipp Müller
Board Member
Nadiya Ishnazarova
Board Member
Xiaoli Huang
Project Director Preclinical Pharmacology
Ignacio Melero
Advisory Board Member
Johanna Olweus
Scientific Advisory Board Member
Shane Olwill
Chief Development Officer
João Ribas
Board Member
Jan Villadsen
Head of Finance
Ulrich Lauer
Advisory Board Member
Jonas Jendi
Board Member
Martin Bonde
Chair of the Board
Joshua Brody
Advisory Board Member
Fiona MacLaughlin
Board Member (Johnson & Johnson Innovation – JJDC, Inc.)
Brian Brown
Advisory Board Member
Aleksei Zeifman
Board Member (RV Invest)
Filipe Pereira
Co-founder and Head of Innovation
Frank Hennecke
Head of CMC
Wolfram Brugger
Chief Medical Officer
Aurélien Marabelle
Advisory Board Member
Cristina Csimma
Independent Board Member
Julie M Cherrington
Advisory Board Member
Övriga kontakter
Iveta Mikalajūnaitė
Team Member
Xavier Catena
Team Member
Emilie Renaud
Team Member
André Rosa
Team Member
+2 fler kontakter i Funnelfeedr
Liknande företag
20 liknande företag i FunnelfeedrSACRA Therapeutics AB
0 anställdaSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Anocca AB
100–199 anställdaEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Lokon Pharma AB
10–19 anställdaDeveloping novel gene engineering vectors for cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Theralia AB
0 anställdaPioneering biotech revolutionizing drug delivery via TOUCAN technology.
Utforska mer
Frågor om Asgard Therapeutics AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo